TME Pharma
Articles of Association (Dutch)
Articles of Association (English translation)
Supervisory Board Rules
Terms of Reference - Audit Committee
Terms of Reference - Compensation Committee
Terms of Reference - Nomination and Corporate Governance Committee
Code of Conduct
Insider Trading Policy
Diversity Policy
Policy on Bilateral Contacts
Profile and Composition of the Supervisory Board
Remuneration Policy
Rotation Schedule for the Supervisory Board Directors
Whistleblowing Policy

Board Committees

Audit Committee
• Oscar Izeboud (Chair)
• Susan Coles

Compensation and Nomination
& Corporate Governance Committee

• Susan Coles (Chair)
• Maurizio PetitBon

 


Shareholders Meetings

2023 AGM

Presentation of the AGM (with voting results) held on June 29, 2023
Minutes of the AGM held on June 29, 2023

Notice is hereby given that the annual general meeting of shareholders (the General Meeting) of TME Pharma N.V. (the Company) is convened at 13.30 hours (CEST) on 29 June 2023 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands. The language of the meeting shall be English.

The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.

Downloads

2023 AGM Notice and Agenda
2023 AGM Attendance Notice and PoA
2023 AGM Agenda item 6 partial amendment AoA NL
2023 AGM Agenda item 6 partial amendment AoA EN informal Translation
2022 Annual Report

2023 EGM

Minutes of the EGM held on January 30, 2023

Notice is hereby given that the extraordinary general meeting of shareholders (the General Meeting) of TME Pharma N.V. (the Company) is convened at 13.30 (CET) on 30 January 2023 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands. The language of the meeting shall be English.

The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.

Downloads

2023 EGM Notice and Agenda
2023 EGM Attendance Notice and PoA
2023 EGM Agenda item 2 partial amendment AoA NL
2023 EGM Agenda item 2 partial amendment AoA EN informal translation
2023 EGM Agenda item 3 partial amendment AoA NL
2023 EGM Agenda item 3 partial amendment AoA EN informal translation

2022 AGM

Presentation of the AGM (with voting results) held on June 29, 2022
Minutes of the AGM held on June 29, 2022

Notice is hereby given that the annual general meeting of shareholders (the General Meeting) of NOXXON Pharma N.V. (the Company) is convened at 14.00 hours (CEST) on 29 June 2022 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands. The language of the meeting shall be English.

The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.

Downloads

2022 AGM Notice and Agenda
2022 AGM Attendance Notice and PoA
2022 AGM Agenda item 6,7,8 partial amendment AoA NL
2022 AGM Agenda item 6,7,8 partial amendment AoA EN informal Translation
2021 Annual Report

2022 EGM

Minutes of the EGM held on May 16, 2022

Notice is hereby given that the extraordinary general meeting of shareholders (the “General Meeting”) of NOXXON Pharma N.V. (the “Company”) is convened at 13.30 hours (CET) on 16 May 2022 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands. The language of the meeting shall be English.

The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.

Downloads

2022 EGM Notice and Agenda
2022 EGM Attendance Notice and PoA
2022 EGM Agenda item 2 partial amendment AoA NL
2022 EGM Agenda item 2 partial amendment AoA EN informal translation

2021 EGM

Minutes of the EGM held on December 15, 2021

Notice is hereby given that the extraordinary general meeting of shareholders (the “General Meeting”) of NOXXON Pharma N.V. (the “Company”) is convened at 15.00 hours (CET) on 15 December 2021 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands. The language of the meeting shall be English.

In light of the public health risks arising from outbreak of the COVID-19 virus and restrictive measures in the Netherlands and elsewhere implemented to reduce gatherings of people, the Company urges its shareholders not to attend the General Meeting in person. You do not need to be present to cast your vote at the General Meeting on 15 December 2021. Instead, please give your voting instructions by proxy. Further details on proxy voting are given in the Attendance Notice for this General Meeting available on this website.
The Company acknowledges that constraints caused by the outbreak of COVID-19 restrict the physical presence of its shareholders at the General Meeting on 15 December 2021 and thus to ask questions at the General Meeting. For this reason, shareholders who decide not to attend the General Meeting on 15 December 2021 in Amsterdam, the Netherlands, and who wish to submit questions regarding items on the agenda of the General Meeting, may submit their questions by email to This email address is being protected from spambots. You need JavaScript enabled to view it. up to 17:00 (CET) on 12 December 2021. The email submitting such question(s) must include name, surname, number of shares held by the shareholder on the record date for the General Meeting and the agenda item to which the question relates.

The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.

Downloads

2021 EGM Notice and Agenda
2021 EGM Attendance Notice and PoA
2021 Main terms of employment for Bryan Jennings

2021 AGM

Presentation of the AGM (with voting results) held on June 24, 2021
Minutes of the AGM held on June 24, 2021

Notice is hereby given that the annual general meeting of shareholders (the General Meeting) of NOXXON Pharma N.V. (the Company) is convened at 14.00 hours (CEST) on 24 June 2021 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands. The language of the meeting shall be English.
In light of the public health risks arising from outbreak of the COVID-19 virus and restrictive measures in the Netherlands and elsewhere implemented to reduce gatherings of people, the Company urges its shareholders not to attend the General Meeting in person. You do not need to be present to cast your vote at the General Meeting on 24 June 2021. Instead, please give your voting instructions by proxy. Further details on proxy voting are given in the Attendance Notice for this General Meeting available on this website.
The Company acknowledges that constraints caused by the outbreak of the COVID-19 virus restrict the physical presence of its shareholders at the General Meeting on 24 June 2021 and thus to ask questions at the General Meeting. For this reason, shareholders who decide not to attend the General Meeting on 24 June 2021 in Amsterdam, the Netherlands, and who wish to submit questions regarding items on the agenda of the General Meeting, may submit their questions by email to This email address is being protected from spambots. You need JavaScript enabled to view it. up to 17:00 (CEST) on Monday 21 June 2021. The email submitting such question(s) must include name, surname, number of shares held by the shareholder on the record date for the General Meeting and the agenda item to which the question relates.

The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.

Downloads

2021 AGM Notice and Agenda
2021 AGM Attendance Notice and PoA
2021 AGM Agenda item 6 partial amendment AoA NL
2021 AGM Agenda item 6 partial amendment AoA EN informal Translation
2021 AGM Agenda item 7 partial amendment AoA NL
2021 AGM Agenda item 7 partial amendment AoA EN informal Translation
2020 Annual Report

2020 AGM

Presentation of the AGM (with voting results) held on June 30, 2020
Minutes of the AGM held on June 30, 2020

Notice is hereby given that the annual general meeting of shareholders (the General Meeting) of NOXXON Pharma N.V. (the Company) is convened at 10.30 hours (CEST) on 30 June 2020 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands.
In light of the public health risks arising from outbreak of COVID-19 and restrictive measures in the Netherlands and elsewhere implemented to reduce gatherings of people, the Company urges its shareholders not to attend the General Meeting in person. You do not need to be present to cast your vote at the General Meeting on 30 June 2020. Instead, please give your voting instructions by proxy. Further details on proxy voting are given in the Attendance Notice for this General Meeting available on this website.
The Company acknowledges that constraints caused by the outbreak of COVID-19 restrict the physical presence of its shareholders at the General Meeting on 30 June 2020 and thus to ask questions at the General Meeting. For this reason, shareholders who decide not to attend the General Meeting on 30 June 2020 in Amsterdam, the Netherlands, and who wish to submit questions regarding items on the AGM agenda, may submit their questions by email to This email address is being protected from spambots. You need JavaScript enabled to view it. up to 10.30 hours (CEST) on Friday 26 June 2020. The email submitting such question(s) must include name, surname, number of shares held by the shareholder on the Registration Date (as defined below) for the General Meeting and the agenda item to which the question relates.

The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.

Downloads

2020 AGM Notice and Agenda
2020 AGM Attendance Notice and PoA
2020 AGM Partial Amendment AoA
2019 Annual Report

2019 AGM

Minutes of the AGM held on June 25, 2019

Notice is hereby given that the General Meeting of Shareholders (the General Meeting) of NOXXON Pharma N.V. (the Company) is convened at 13.30 hours (CEST) on June 25, 2019 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands.

The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.

Downloads

2019 AGM Notice and Agenda
2019 AGM Attendance Notice and PoA
2018 Annual Report

2019 EGM

Minutes of the EGM held on January 02, 2019

Notice is hereby given that an extra-ordinary general meeting of shareholders (the EGM) of NOXXON Pharma N.V. (the Company) is convened at 13.30 hours (CET) on January 02, 2019 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands.

The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.

Downloads

2019 EGM Notice and Agenda
2019 EGM Attendance Notice and PoA
2019 EGM Agenda item 2-5 partial amendment AoA NL
2019 EGM Agenda item 2-5 partial amendment AoA EN informal Translation

2018 AGM

Minutes of the AGM held on June 20, 2018

Notice is hereby given that the General Meeting of Shareholders (the General Meeting) of NOXXON Pharma N.V. (the Company) is convened at 13.30 hours (CEST) on June 20, 2018 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands.

The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.

Downloads

2018 AGM Notice and Agenda
2018 AGM Attendance Notice and PoA
2018 AGM Agenda item 6 partial amendment AoA NL
2018 AGM Agenda item 6 partial amendment AoA EN informal Translation
2017 Annual Report

2018 EGM

Minutes of the EGM held on April 24,2018

Notice is hereby given that an extra-ordinary general meeting of shareholders (the EGM) of NOXXON Pharma N.V. (the Company) is convened at 13.30 hours (CEST) on April 24, 2018 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands.

The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.

Downloads

2018 EGM Notice and Agenda
2018 EGM Attendance Notice and PoA
2018 EGM Agenda item 2 partial amendment AoA NL
2018 EGM Agenda item 2 partial amendment AoA EN informal Translation

2017 AGM

Minutes of the AGM held on June 27, 2017

Notice is hereby given that the General Meeting of Shareholders (the General Meeting) of NOXXON Pharma N.V. (the Company) is convened at 13.30 hours (CET) on June 27, 2017 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands.

The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.

Downloads

2017 AGM Notice and Agenda
2017 AGM Attendance Notice and PoA
2017 AGM Agenda item 4 partial amendment AoA NL
2017 AGM Agenda item 4 partial amendment AoA EN informal Translation
2016 Annual Report

NOXXON Pharma N.V. announced today that it will hold its annual general meeting of shareholders (“AGM”) on June 27, 2017 in Amsterdam, the Netherlands.
The 2016 annual accounts including the annual report, a formal notice convening the AGM, the agenda of the AGM, the explanatory notes to the agenda, the instructions to participate and vote at the AGM, and other AGM documents will be available on the company’s website (www.noxxon.com) as soon as possible and no later than 15 days prior to the date of the AGM. These documents will also be available at the company's offices at Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany, for shareholders and persons entitled to attend the meeting who, upon request, will receive a copy free of charge. The board of directors has decided that it will apply a registration date for the determination of the persons entitled to attend and to vote at the AGM, which date is the 28th day prior to the AGM pursuant to Dutch law. To be eligible to attend and to vote at the AGM, persons must be registered as shareholder in one of the administration records of the intermediaries that are (indirectly) participants in Euroclear France on May 30, 2017 (the “Registration Date”) after all debit and credit entries have been handled as per the Registration Date.

2016 AGM

Minutes of the AGM held on December 22, 2016

Notice is hereby given that the General Meeting of Shareholders (the General Meeting) of NOXXON Pharma N.V. (the Company) is convened at 13.30 hours (CET) on December 22, 2016 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands.

The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.

Downloads

2016 AGM Notice and Agenda
2016 AGM Attendance Notice and PoA
2015 NOXXON Pharma N.V. IFRS

We use cookies

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (Google Analytics cookies). You can decide for yourself whether you want to accept the cookies. Please note that if you refuse cookies, you may no longer be able to use all of the site's functions.